CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-18 | Babu Yarlagadda S Senior VP - Drug Discovery | Purchase | +25,000 | $1.45 | $36K | 155,587 |
| 2019-11-18 | ASELAGE STEVE Director | Purchase | +15,000 | $1.45 | $22K | 21,672 |
| 2019-09-20 | Thackray Helen M. Director | Grant or award · Non-Qualified Stock Option | +40,000 | 40,000 | ||
| 2019-09-01 | HEGGIE THERESA Director | Grant or award | +1,672 | $2.99 | $5K | 1,672 |
| 2019-09-01 | ASELAGE STEVE Director | Grant or award | +1,672 | $2.99 | $5K | 6,672 |
| 2019-09-01 | Hutson Nancy J Director | Grant or award | +3,344 | $2.99 | $10K | 43,046 |
| 2019-09-01 | INGRAM ROBERT ALEXANDER Director | Grant or award | +6,270 | $2.99 | $19K | 28,088 |
| 2019-07-01 | Sniecinski Megan Chief Business Officer | Grant or award · Emp. Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2019-05-29 | LEE KENNETH B JR Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2019-05-29 | INGRAM ROBERT ALEXANDER Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2019-05-29 | Hutson Nancy J Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2019-05-29 | HEGGIE THERESA Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2019-05-29 | ASELAGE STEVE Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2019-05-29 | ABERCROMBIE GEORGE B Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2019-05-22 | ASELAGE STEVE Director | Purchase | +3,000 | $3.57 | $11K | 5,000 |
| 2019-05-17 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −2,500 | $7.45 | $19K | 125,176 |
| 2019-05-16 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +4,750 | $1.42 | $7K | 134,926 |
| 2019-05-16 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −7,250 | $7.72 | $56K | 127,676 |
| 2019-05-16 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −4,750 | 61,000 | ||
| 2019-05-15 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +4,750 | $1.42 | $7K | 137,426 |
Page 28 of 38 · 750 trades